NASDAQ
TELA

Tela Bio Inc

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

Tela Bio Inc Stock Price

Vitals

Today's Low:
$8.77
Today's High:
$8.965
Open Price:
$8.84
52W Low:
$6.4
52W High:
$13.18
Prev. Close:
$8.92
Volume:
64438

Company Statistics

Market Cap.:
$233.61 million
Book Value:
1.634
Revenue TTM:
$49.18 million
Operating Margin TTM:
-82.43%
Gross Profit TTM:
$27.85 million
Profit Margin:
-88.46%
Return on Assets TTM:
-34.78%
Return on Equity TTM:
-226.24%

Company Profile

Tela Bio Inc had its IPO on 2019-11-08 under the ticker symbol TELA.

The company operates in the Healthcare sector and Medical Devices industry. Tela Bio Inc has a staff strength of 173 employees.

Stock update

Shares of Tela Bio Inc opened at $8.84 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $8.77 - $8.97, and closed at $8.9.

This is a -0.22% slip from the previous day's closing price.

A total volume of 64,438 shares were traded at the close of the day’s session.

In the last one week, shares of Tela Bio Inc have slipped by -6.71%.

Tela Bio Inc's Key Ratios

Tela Bio Inc has a market cap of $233.61 million, indicating a price to book ratio of 8.798 and a price to sales ratio of 5.3206.

In the last 12-months Tela Bio Inc’s revenue was $49.18 million with a gross profit of $27.85 million and an EBITDA of $-39701000. The EBITDA ratio measures Tela Bio Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Tela Bio Inc’s operating margin was -82.43% while its return on assets stood at -34.78% with a return of equity of -226.24%.

In Q2, Tela Bio Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 39.3%.

Tela Bio Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-2.15 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Tela Bio Inc’s profitability.

Tela Bio Inc stock is trading at a EV to sales ratio of 5.0008 and a EV to EBITDA ratio of -5.0205. Its price to sales ratio in the trailing 12-months stood at 5.3206.

Tela Bio Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$94.39 million
Total Liabilities
$13.05 million
Operating Cash Flow
$-157000.00
Capital Expenditure
$157000
Dividend Payout Ratio
0%

Tela Bio Inc ended 2024 with $94.39 million in total assets and $0 in total liabilities. Its intangible assets were valued at $94.39 million while shareholder equity stood at $40.01 million.

Tela Bio Inc ended 2024 with $0 in deferred long-term liabilities, $13.05 million in other current liabilities, 24000.00 in common stock, $-297042000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $65.27 million and cash and short-term investments were $65.27 million. The company’s total short-term debt was $343,000 while long-term debt stood at $40.21 million.

Tela Bio Inc’s total current assets stands at $89.17 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $7.89 million compared to accounts payable of $2.25 million and inventory worth $14.10 million.

In 2024, Tela Bio Inc's operating cash flow was $-157000.00 while its capital expenditure stood at $157000.

Comparatively, Tela Bio Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$8.9
52-Week High
$13.18
52-Week Low
$6.4
Analyst Target Price
$17.6

Tela Bio Inc stock is currently trading at $8.9 per share. It touched a 52-week high of $13.18 and a 52-week low of $13.18. Analysts tracking the stock have a 12-month average target price of $17.6.

Its 50-day moving average was $9.55 and 200-day moving average was $10.26 The short ratio stood at 6.06 indicating a short percent outstanding of 0%.

Around 123.2% of the company’s stock are held by insiders while 6705.1% are held by institutions.

Frequently Asked Questions About Tela Bio Inc

The stock symbol (also called stock or share ticker) of Tela Bio Inc is TELA

The IPO of Tela Bio Inc took place on 2019-11-08

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
$337.95
-17.7
-4.98%
$2264.55
-76.6
-3.27%
$56.32
-0.94
-1.64%
$3.75
0.1
+2.74%
$290.15
-9.05
-3.02%
$871.3
3.6
+0.41%
$3.04
0.05
+1.67%
$3.61
-0.19
-5%
AGI Infra Ltd (AGIIL)
$584.55
-43.45
-6.92%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Address

1 Great Valley Parkway, Malvern, PA, United States, 19355